Keywords: kinemed, enters, two-year, ad, collaboration, bristol-myers, squibb
KineMed enters two-year AD collaboration with Bristol-Myers Squibb
Article | 28 May 2009
USA-based KineMed, a translational and personalized medicine development company, has entered a two-year collaboration with Bristol-Myers Squibb for the development ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
